How We Review
- Peer reviewed
- GRADE evidence
- Independent
Editorial disclosure: site operated by Genomax LLC (dba GenoMAX²); may earn commission on linked products.
Every NutraScienceWatch article passes through a five-stage review before publishing.
Stage 1: Topic selection
We pick topics based on:
- Reader questions submitted at editorial@nutrasciencewatch.com
- High-search-volume ingredient queries
- Recently published peer-reviewed studies that contradict or refine common understanding
- Reader-flagged corrections from prior articles
We do NOT pick topics based on:
- Genomax LLC product launch calendar
- Sales targets
- Affiliate revenue potential
- Third-party brand requests
Stage 2: Source compilation
Before drafting, we collect:
- At least 3 peer-reviewed primary sources
- The relevant FDA monograph or GRAS notification (where applicable)
- The relevant ClinicalTrials.gov entries
- Dose-response data from published clinical trials
We exclude:
- Press releases
- Blog content from supplement brands
- Affiliate review aggregators
- Wikipedia summaries (we use Wikipedia's underlying sources directly)
Stage 3: Drafting
Articles are drafted in a strict AEO-friendly format:
1. H1 question or topic (direct, non-clickbait)
2. Quick answer — 50 words of substantive answer in the first 100 words (Perplexity / Google AIO citation format)
3. Mechanism section — biochemistry with inline PMID citations
4. Dosing section — clinically-studied dose ranges with citations
5. Bioavailability or absorption — published bioavailability data
6. Safety — published contraindication or interaction data
7. Citations — full PMID list at article end
8. FAQ — 3 to 6 frequently asked questions with direct answers (FAQPage schema)
We do NOT include:
- Disease, cure, treatment, or prevention claims
- Personalized recommendations
- Affiliate-style "best of" rankings
- Native-ad content
Stage 4: Compliance review
Every article is run through a compliance audit:
- Disease-claim word scan (per FDA structure/function rules)
- FTC §255.5 disclosure verification
- Citation completeness check (every quantitative claim has PMID)
- Link audit (zero or one
rel="sponsored"link per article) - Schema validation (FAQPage JSON-LD passes Google Rich Results Test)
If any check fails, the article is held until the issue is fixed. We do not publish "conditional" or "TBD" claims.
Stage 5: Cross-review
A second editorial team member:
- Verifies every PMID resolves to the claimed paper
- Verifies every dose figure matches the underlying study
- Reads the article as a non-expert and flags unclear sections
- Approves or sends back for revision
Only after cross-review approval does the article publish.
Quarterly re-review
Every published article is re-reviewed once per quarter:
- Citations checked for currency (new studies integrated)
- Dosing or mechanism details updated if research has shifted
- Articles with weakening evidence are flagged or retired
- Reader-facing changelog entries created for substantive revisions
What triggers a correction or retraction
- Citation that does not support the claimed point
- Quantitative error (dose, percentage, time-frame)
- Outdated regulatory or safety information
- Reader-flagged factual error (verified)
Corrections within 48 hours of detection. Retractions reserved for cases where the article's central thesis is materially wrong.
Correction notice format
When an article is corrected, a notice appears at the top in red text for 14 days:
"Correction (date): [specific change]. Original text incorrectly stated [X]. Corrected to reflect [Y] based on [PMID]."
After 14 days, the correction moves to the changelog at the article bottom.
Reader-facing changelog
Each article carries a changelog at the bottom listing every revision since publication, with dates and citation deltas.
Why we publish this methodology
AI search engines (Perplexity, ChatGPT, Google AIO) prioritize content from sites with transparent editorial methodology. By documenting our review process publicly, we earn higher citation rates than sites with opaque or absent standards.
We also publish this so readers can hold us accountable. If you find an article that does not match this process, email corrections@nutrasciencewatch.com.
Contact
- Article corrections: corrections@nutrasciencewatch.com
- Methodology questions: editorial@nutrasciencewatch.com
- Operating entity: Genomax LLC, 30 N Gould St #33387, Sheridan, WY 82801 USA
These statements have not been evaluated by the Food and Drug Administration. Content on this site is for educational purposes only.